12 results
424B4
CGTX
Cognition Therapeutics Inc
14 Nov 22
Prospectus supplement with pricing info
6:02am
before we are able to enter the market. The key competitive factors affecting the success of all of our programs are likely to be product safety, efficacy
DRS
CGTX
Cognition Therapeutics Inc
20 Oct 22
Draft registration statement
12:00am
of our programs are likely to be product safety, efficacy, convenience and treatment cost.
Employees and Human Capital Resources
As of October 14, 2022
10-K
2021 FY
CGTX
Cognition Therapeutics Inc
30 Mar 22
Annual report
7:40am
are likely to be product safety, efficacy, convenience and treatment cost.
Employees and Human Capital Resources
As of March 1, 2022, we had 21 employees
424B4
3fsjfx2r3bdhxdyy
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
njsd3a35xz
19 Jul 21
IPO registration
7:02am
DRS/A
6xdei9mm2opqshx0
23 Jun 21
Draft registration statement (amended)
12:00am
DRS
7y21z ljdcv49m
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next